Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
ETFs with BMY as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|7.27%||iShares U.S. Pharmaceutical ETF (IHE)||+25.93 (24.55%)|
|5%||Merrill Lynch Pharmaceutical HOLDRS (PPH)||+11.53 (24.09%)|
|4.96%||PowerShares Dynamic Pharmaceuticals (PJP)||+13.07 (28.23%)|
|4.1%||Select Sector SPDR Fund - Health Care (XLV)||+8.61 (16.89%)|
|3.9%||Columbia Select Large Cap Value ETF (GVT)||+5.22 (13.80%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Bristol-Myers Squibb Company (which may be referred to as Bristol-Myers Squibb, BMS, the Company, we, our or us) was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business started in 1887. In 1989, Bristol-Myers Company changed its name to Bristol-Myers Squibb Company as a result of a merger. We are engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. We operate in one segment—BioPharmaceuticals. For additional information about business segments, see “Item 8. Financial Statements—Note 2. Business Segment Information.” We compete with other worldwide research-based drug companies, smaller research companies and generic drug manufacturers. Our products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. ... More ...
|Annual EPS Est:||$1.82|
|Quarterly EPS Est:||0.46|